vs
Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and BWX Technologies, Inc. (BWXT). Click either name above to swap in a different company.
Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.2B vs $885.8M, roughly 1.4× BWX Technologies, Inc.). BWX Technologies, Inc. runs the higher net margin — 10.5% vs 0.9%, a 9.6% gap on every dollar of revenue. On growth, BWX Technologies, Inc. posted the faster year-over-year revenue change (18.7% vs -74.7%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (34.6% CAGR vs 21.1%).
Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.
BWX Technologies, Inc. is a company headquartered in Lynchburg, Virginia that supplies nuclear components and fuel internationally.
ALHC vs BWXT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2B | $885.8M |
| Net Profit | $11.4M | $93.0M |
| Gross Margin | — | — |
| Operating Margin | — | 10.4% |
| Net Margin | 0.9% | 10.5% |
| Revenue YoY | -74.7% | 18.7% |
| Net Profit YoY | — | 30.9% |
| EPS (diluted) | — | $1.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.0B | $885.8M | ||
| Q3 25 | $993.7M | $866.3M | ||
| Q2 25 | $1.0B | $764.0M | ||
| Q1 25 | $926.9M | $682.3M | ||
| Q4 24 | $701.2M | $746.3M | ||
| Q3 24 | $692.4M | $672.0M | ||
| Q2 24 | $681.3M | $681.5M |
| Q1 26 | $11.4M | — | ||
| Q4 25 | $-11.0M | $93.0M | ||
| Q3 25 | $3.7M | $82.1M | ||
| Q2 25 | $15.7M | $78.4M | ||
| Q1 25 | $-9.1M | $75.5M | ||
| Q4 24 | $-31.1M | $71.0M | ||
| Q3 24 | $-26.4M | $69.5M | ||
| Q2 24 | $-24.0M | $73.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 21.8% | ||
| Q2 25 | — | 25.1% | ||
| Q1 25 | — | 24.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 24.4% | ||
| Q2 24 | — | 24.7% |
| Q1 26 | — | — | ||
| Q4 25 | -1.0% | 10.4% | ||
| Q3 25 | 0.8% | 13.1% | ||
| Q2 25 | 2.2% | 13.4% | ||
| Q1 25 | -0.6% | 14.2% | ||
| Q4 24 | -3.2% | 12.4% | ||
| Q3 24 | -2.8% | 14.4% | ||
| Q2 24 | -2.7% | 14.5% |
| Q1 26 | 0.9% | — | ||
| Q4 25 | -1.1% | 10.5% | ||
| Q3 25 | 0.4% | 9.5% | ||
| Q2 25 | 1.5% | 10.3% | ||
| Q1 25 | -1.0% | 11.1% | ||
| Q4 24 | -4.4% | 9.5% | ||
| Q3 24 | -3.8% | 10.3% | ||
| Q2 24 | -3.5% | 10.7% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.04 | $1.02 | ||
| Q3 25 | $0.02 | $0.89 | ||
| Q2 25 | $0.07 | $0.85 | ||
| Q1 25 | $-0.05 | $0.82 | ||
| Q4 24 | $-0.15 | $0.77 | ||
| Q3 24 | $-0.14 | $0.76 | ||
| Q2 24 | $-0.13 | $0.79 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $705.6M | $499.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $206.9M | $1.2B |
| Total Assets | $1.3B | $4.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $705.6M | — | ||
| Q4 25 | $604.2M | $499.8M | ||
| Q3 25 | $644.1M | $79.6M | ||
| Q2 25 | $503.8M | $37.0M | ||
| Q1 25 | $479.5M | $55.4M | ||
| Q4 24 | $470.6M | $74.1M | ||
| Q3 24 | $381.0M | $35.5M | ||
| Q2 24 | $363.7M | $48.3M |
| Q1 26 | — | — | ||
| Q4 25 | $323.2M | — | ||
| Q3 25 | $322.7M | — | ||
| Q2 25 | $322.3M | — | ||
| Q1 25 | $321.9M | — | ||
| Q4 24 | $321.4M | — | ||
| Q3 24 | $212.0M | — | ||
| Q2 24 | $211.7M | — |
| Q1 26 | $206.9M | — | ||
| Q4 25 | $179.3M | $1.2B | ||
| Q3 25 | $161.9M | $1.2B | ||
| Q2 25 | $141.0M | $1.2B | ||
| Q1 25 | $108.1M | $1.1B | ||
| Q4 24 | $99.9M | $1.1B | ||
| Q3 24 | $114.5M | $1.1B | ||
| Q2 24 | $123.7M | $998.5M |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.1B | $4.3B | ||
| Q3 25 | $1.1B | $3.8B | ||
| Q2 25 | $1.0B | $3.7B | ||
| Q1 25 | $895.6M | $3.1B | ||
| Q4 24 | $782.1M | $2.9B | ||
| Q3 24 | $692.3M | $2.9B | ||
| Q2 24 | $716.3M | $2.8B |
| Q1 26 | — | — | ||
| Q4 25 | 1.80× | — | ||
| Q3 25 | 1.99× | — | ||
| Q2 25 | 2.29× | — | ||
| Q1 25 | 2.98× | — | ||
| Q4 24 | 3.22× | — | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 1.71× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $128.7M | $127.0M |
| Free Cash FlowOCF − Capex | — | $56.8M |
| FCF MarginFCF / Revenue | — | 6.4% |
| Capex IntensityCapex / Revenue | — | 7.9% |
| Cash ConversionOCF / Net Profit | 11.27× | 1.37× |
| TTM Free Cash FlowTrailing 4 quarters | — | $295.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $128.7M | — | ||
| Q4 25 | $-50.4M | $127.0M | ||
| Q3 25 | $144.6M | $143.2M | ||
| Q2 25 | $29.1M | $159.0M | ||
| Q1 25 | $16.6M | $50.6M | ||
| Q4 24 | $-8.7M | $276.9M | ||
| Q3 24 | $26.2M | $32.6M | ||
| Q2 24 | $23.5M | $65.9M |
| Q1 26 | — | — | ||
| Q4 25 | $-55.4M | $56.8M | ||
| Q3 25 | $139.1M | $94.9M | ||
| Q2 25 | $21.1M | $126.3M | ||
| Q1 25 | $8.4M | $17.3M | ||
| Q4 24 | $-18.0M | $224.4M | ||
| Q3 24 | $16.9M | $-7.7M | ||
| Q2 24 | $11.8M | $35.5M |
| Q1 26 | — | — | ||
| Q4 25 | -5.5% | 6.4% | ||
| Q3 25 | 14.0% | 11.0% | ||
| Q2 25 | 2.1% | 16.5% | ||
| Q1 25 | 0.9% | 2.5% | ||
| Q4 24 | -2.6% | 30.1% | ||
| Q3 24 | 2.4% | -1.1% | ||
| Q2 24 | 1.7% | 5.2% |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 7.9% | ||
| Q3 25 | 0.6% | 5.6% | ||
| Q2 25 | 0.8% | 4.3% | ||
| Q1 25 | 0.9% | 4.9% | ||
| Q4 24 | 1.3% | 7.0% | ||
| Q3 24 | 1.3% | 6.0% | ||
| Q2 24 | 1.7% | 4.5% |
| Q1 26 | 11.27× | — | ||
| Q4 25 | — | 1.37× | ||
| Q3 25 | 38.77× | 1.74× | ||
| Q2 25 | 1.86× | 2.03× | ||
| Q1 25 | — | 0.67× | ||
| Q4 24 | — | 3.90× | ||
| Q3 24 | — | 0.47× | ||
| Q2 24 | — | 0.90× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALHC
Segment breakdown not available.
BWXT
| Nuclear Component Program | $436.4M | 49% |
| Nuclear Manufacturing | $134.8M | 15% |
| Cost Plus Fee | $116.1M | 13% |
| Uranium And Nuclear Services | $103.8M | 12% |
| Commercial Operations | $49.0M | 6% |
| Commercial Operations Segment | $33.7M | 4% |
| Transferred At Point In Time | $1.3M | 0% |
